樂普醫療(300003.SZ):人工智能“心電分析軟件” (AI-ECG Platform)獲NMPA註冊批准
格隆匯2月6日丨樂普醫療(300003.SZ)公佈,公司於今日獲悉,公司AI事業部下屬全資子公司深圳市凱沃爾電子有限公司自主研製的人工智能“心電分析軟件”(AI-ECG Platform)獲得國家藥品監督管理局(“NMPA”)的註冊批准。即在2018年11月獲得美國食品藥品監督管理局(“FDA”)註冊批准、2019年11月通過歐盟CE註冊認證後,人工智能“心電分析軟件”(AI-ECG Platform)成為國內首款獲批註冊,也是目前唯一一款同時獲得NMPA批准、FDA批准和CE認證的人工智能心電產品。
心電圖是各種心血管疾病最簡單、快捷、經濟的臨牀檢查方法,是心血管疾病檢驗的基石。人工智能“心電分析軟件”(AI-ECG Platform)基於人工智能深度學習技術,使用千萬級的心電圖臨牀大數據進行訓練,通過自動分析心律失常、心肌梗塞、心室肥大和ST-T異常等心電圖事件,總體準確率已達到95%以上,實現了靜態心電圖的快速、準確診斷,同時支持院內院外的心電網絡建設,從而有效提升醫院的信息化、智能化水平。
人工智能“心電分析軟件”(AI-ECG Platform)是樂普醫療在人工智能醫療領域的里程碑產品,基於此技術平台公司已研製出AI芯片靜電圖機等多項設備,提供涵蓋院前篩查、院中檢查和監護、院後康復監測的全流程化解決方案,助力國內外醫院心電信息化建設,提升心電圖診療效率和服務水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.